LM-108
- Generic Name
- LM-108
A Study of LM-108 in Combination With Toripalimab in Subjects With Advanced Solid Tumours
- First Posted Date
- 2025-03-13
- Last Posted Date
- 2025-03-13
- Lead Sponsor
- LaNova Medicines Limited
- Target Recruit Count
- 84
- Registration Number
- NCT06873854
- Locations
- 🇨🇳
Beijing Cancer Hospital, Beijing, Beijing, China
LM-108 in Combination With PD-1 Based Treatment for Patients With Recurrent or Metastatic Triple - Negative Breast Cancer
Phase 2
Recruiting
- Conditions
- TNBC - Triple-Negative Breast Cancer
- Interventions
- First Posted Date
- 2024-04-29
- Last Posted Date
- 2024-08-02
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 74
- Registration Number
- NCT06387628
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
Study of LM-108 as a Single Agent or in Combination With Toripalimab in Subjects With Advanced Solid Tumours
- First Posted Date
- 2022-08-26
- Last Posted Date
- 2024-10-14
- Lead Sponsor
- LaNova Medicines Limited
- Target Recruit Count
- 392
- Registration Number
- NCT05518045
- Locations
- 🇨🇳
Beijing Cancer Hospital, Beijing, China
Study of LM-108 as a Single Agent or in Combination With Pembrolizumab in Subjects With Advanced Solid Tumours
- First Posted Date
- 2022-02-24
- Last Posted Date
- 2023-10-25
- Lead Sponsor
- LaNova Medicines Limited
- Target Recruit Count
- 24
- Registration Number
- NCT05255484
- Locations
- 🇺🇸
University of Oklahoma, Norman, Oklahoma, United States
🇺🇸Gabrail Cancer and Research Center, Canton, Ohio, United States
🇺🇸Ocala Oncology Center, Ocala, Florida, United States
Study of LM-108 as a Single Agent or in Combination With Anti-PD-1 Antibody in Subjects With Advanced Solid Tumours
- First Posted Date
- 2022-01-20
- Last Posted Date
- 2024-10-11
- Lead Sponsor
- LaNova Australia Pty Limited
- Target Recruit Count
- 60
- Registration Number
- NCT05199753
- Locations
- 🇦🇺
ICON Cancer Centre, South Brisbane, Queensland, Australia
🇦🇺Sunshine Coast University Private Hospital, Birtinya, Queensland, Australia
🇦🇺Blacktown Hospital, Sydney, New South Wales, Australia
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath